France Glaucoma , 2030 Market Size & Outlook, 2022-2030
Related Markets
France glaucoma market , 2030 highlights
- The France glaucoma market , 2030 generated a revenue of USD 232.5 million in 2022 and is expected to reach USD 312.1 million by 2030.
- The France market is expected to grow at a CAGR of 3.7% from 2023 to 2030.
- In terms of segment, open angle glaucoma was the largest revenue generating disease type in 2022.
- Open Angle Glaucoma is the most lucrative disease type segment registering the fastest growth during the forecast period.
Glaucoma market , 2030 data book summary
| Market revenue in 2022 | USD 232.5 million |
| Market revenue in 2030 | USD 312.1 million |
| Growth rate | 3.7% (CAGR from 2022 to 2030) |
| Largest segment | Open angle glaucoma |
| Fastest growing segment | Open Angle Glaucoma |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Open Angle Glaucoma, Angle Closure Glaucoma, Others Disease Type |
| Key market players worldwide | Pfizer Inc, Santen Pharmaceutical Co Ltd, Novartis AG ADR, Alcon Inc, Akron Biotechnology, AbbVie Inc, Bausch & Lomb Corp, Teva Pharmaceutical Industries Ltd |
Other key industry trends
- In terms of revenue, France accounted for 2.9% of the global glaucoma market , 2030 in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany glaucoma market , 2030 is projected to lead the regional market in terms of revenue in 2030.
- Italy is the fastest growing regional market in Europe and is projected to reach USD 300.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Glaucoma Market , 2030 Scope
Glaucoma Market , 2030 Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Akron Biotechnology | View profile | 11-50 | Boca Raton, Florida, United States, North America | https://www.akronbiotech.com |
| Santen Pharmaceutical Co Ltd | View profile | 1807 | Grand Front Osaka Tower A, 4-20 Ofuka-cho, Kita-ku, Osaka, Japan, 530-8552 | http://www.santen.co.jp |
| Bausch & Lomb Corp | View profile | 13300 | 520 Applewood Crescent, Vaughan, ON, Canada, L4K 4B4 | https://www.bausch.com |
| Alcon Inc | View profile | 25315 | Chemin de Blandonnet 8, Royce Bedward, Vernier, Geneva, Switzerland, 1214 | https://www.alcon.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
France glaucoma market , 2030 outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to glaucoma market , 2030 will help companies and investors design strategic landscapes.
Open angle glaucoma was the largest segment with a revenue share of 75.7% in 2022. Horizon Databook has segmented the France glaucoma market , 2030 based on open angle glaucoma, angle closure glaucoma, others disease type covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to France glaucoma market , 2030 databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of France glaucoma market , 2030 databook
-
Our clientele includes a mix of glaucoma market , 2030 companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the France glaucoma market , 2030, including forecasts for subscribers. This country databook contains high-level insights into France glaucoma market , 2030 from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
France glaucoma market report size, by disease type, 2018-2030 (US$M)
France Glaucoma Market Outlook, 2030 Share, 2022 & 2030 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
